1
|
Tsai C, Nguyen B, Luthra A, Chou JF, Feder L, Tang LH, Strong VE, Molena D, Jones DR, Coit DG, Ilson DH, Ku GY, Cowzer D, Cadley J, Capanu M, Schultz N, Beal K, Moss NS, Janjigian YY, Maron SB. Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma. JAMA Netw Open 2022; 5:e2228083. [PMID: 36001319 PMCID: PMC9403772 DOI: 10.1001/jamanetworkopen.2022.28083] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
IMPORTANCE Brain metastasis (BrM) in gastroesophageal adenocarcinoma (GEA) is a rare and poorly understood phenomenon associated with poor prognosis. OBJECTIVES To examine the clinical and genomic features of patients with BrM from GEA and evaluate factors associated with survival. DESIGN, SETTING, AND PARTICIPANTS In this single-institution retrospective cohort study, 68 patients with BrM from GEA diagnosed between January 1, 2008, and December 31, 2020, were identified via review of billing codes and imaging reports from the electronic medical record with follow-up through November 3, 2021. Genomic data were derived from the Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets clinical sequencing platform. EXPOSURES Treatment with BrM resection and/or radiotherapy. MAIN OUTCOMES AND MEASURES Overall survival after BrM diagnosis. RESULTS Sixty-eight patients (median age at diagnosis, 57.4 years [IQR, 49.8-66.4 years]; 59 [86.8%] male; 55 [85.9%] White) participated in the study. A total of 57 (83.8%) had primary tumors in the distal esophagus or gastroesophageal junction. Median time from initial diagnosis to BrM diagnosis was 16.9 months (IQR, 8.5-27.7 months). Median survival from BrM diagnosis was 8.7 months (95% CI, 5.5-11.5 months). Overall survival was 35% (95% CI, 25%-48%) at 1 year and 24% (95% CI, 16%-37%) at 2 years. In a multivariable analysis, an Eastern Cooperative Oncology Group performance status of 2 or greater (hazard ratio [HR], 4.66; 95% CI, 1.47-14.70; P = .009) and lack of surgical or radiotherapeutic intervention (HR, 7.71; 95% CI, 2.01-29.60; P = .003) were associated with increased risk of all-cause mortality, whereas 3 or more extracranial sites of disease (HR, 1.85; 95% CI, 0.64-5.29; P = .25) and 4 or more BrMs (HR, 2.15; 95% CI, 0.93-4.98; P = .07) were not statistically significant. A total of 31 patients (45.6%) had ERBB2 (formerly HER2 or HER2/neu)-positive tumors, and alterations in ERBB2 were enriched in BrM relative to primary tumors (8 [47.1%] vs 7 [20.6%], P = .05), as were alterations in PTPRT (7 [41.2%] vs 4 [11.8%], P = .03). CONCLUSIONS AND RELEVANCE This study suggests that that a notable proportion of patients with BrM from GEA achieve survival exceeding 1 and 2 years from BrM diagnosis, a more favorable prognosis than previously reported. Good performance status and treatment with combination surgery and radiotherapy were associated with the best outcomes. ERBB2 positivity and amplification as well as PTPRT alterations were enriched in BrM tissue compared with primary tumors; therefore, further study should be pursued to identify whether these variables represent genomic risk factors for BrM development.
Collapse
Affiliation(s)
- Charlton Tsai
- Department of Medicine, New York Presbyterian/Weill Cornell Medicine, New York, New York
| | - Bastien Nguyen
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Anisha Luthra
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Joanne F. Chou
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Lara Feder
- Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Laura H. Tang
- Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Vivian E. Strong
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Daniela Molena
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
| | - David R. Jones
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Daniel G. Coit
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
| | - David H. Ilson
- Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Geoffrey Y. Ku
- Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Darren Cowzer
- Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - John Cadley
- Department of Digital Informatics and Technology Solutions, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Marinela Capanu
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Nikolaus Schultz
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Kathryn Beal
- Department of Radiation Oncology and Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Nelson S. Moss
- Department of Neurosurgery and Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Yelena Y. Janjigian
- Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Steven B. Maron
- Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
| |
Collapse
|
2
|
Pereira C, Arroyo-Martinez GA, Guo MZ, Downey MS, Kelly ER, Grive KJ, Mahadevaiah SK, Sims JR, Faca VM, Tsai C, Schiltz CJ, Wit N, Jacobs H, Clark NL, Freire R, Turner J, Lyndaker AM, Brieno-Enriquez MA, Cohen PE, Smolka MB, Weiss RS. Multiple 9-1-1 complexes promote homolog synapsis, DSB repair, and ATR signaling during mammalian meiosis. eLife 2022; 11:68677. [PMID: 35133274 PMCID: PMC8824475 DOI: 10.7554/elife.68677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2021] [Accepted: 01/15/2022] [Indexed: 11/13/2022] Open
Abstract
DNA damage response mechanisms have meiotic roles that ensure successful gamete formation. While completion of meiotic double-strand break (DSB) repair requires the canonical RAD9A-RAD1-HUS1 (9A-1-1) complex, mammalian meiocytes also express RAD9A and HUS1 paralogs, RAD9B and HUS1B, predicted to form alternative 9-1-1 complexes. The RAD1 subunit is shared by all predicted 9-1-1 complexes and localizes to meiotic chromosomes even in the absence of HUS1 and RAD9A. Here, we report that testis-specific disruption of RAD1 in mice resulted in impaired DSB repair, germ cell depletion, and infertility. Unlike Hus1 or Rad9a disruption, Rad1 loss in meiocytes also caused severe defects in homolog synapsis, impaired phosphorylation of ATR targets such as H2AX, CHK1, and HORMAD2, and compromised meiotic sex chromosome inactivation. Together, these results establish critical roles for both canonical and alternative 9-1-1 complexes in meiotic ATR activation and successful prophase I completion.
Collapse
Affiliation(s)
| | | | - Matthew Z Guo
- Department of Biomedical Sciences, Cornell University
| | | | - Emma R Kelly
- Division of Mathematics and Natural Sciences, Elmira College
| | | | | | - Jennie R Sims
- Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University
| | - Vitor M Faca
- Department of Biochemistry and Immunology, FMRP, University of São Paulo
| | - Charlton Tsai
- Department of Biomedical Sciences, Cornell University
| | | | - Niek Wit
- Division of Immunology, The Netherlands Cancer Institute
| | - Heinz Jacobs
- Division of Immunology, The Netherlands Cancer Institute
| | | | - Raimundo Freire
- Unidad de Investigación, Hospital Universitario de Canarias
- Instituto de Tecnologías Biomédicas, Universidad de La Laguna
- Universidad Fernando Pessoa Canarias
| | - James Turner
- Sex Chromosome Biology Laboratory, The Francis Crick Institute
| | - Amy M Lyndaker
- Division of Mathematics and Natural Sciences, Elmira College
| | - Miguel A Brieno-Enriquez
- Magee-Womens Research Institute, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh
| | - Paula E Cohen
- Department of Biomedical Sciences, Cornell University
| | - Marcus B Smolka
- Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University
| | | |
Collapse
|
3
|
Tsai C, Nguyen B, Luthra A, Chou JF, Tang LH, Strong VE, Molena D, Jones DR, Coit DG, Ilson DH, Ku GY, Moss NS, Beal K, Capanu M, Schultz N, Janjigian YY, Maron SB. Brain metastasis in gastroesophageal adenocarcinoma: Outcomes and molecular features. J Clin Oncol 2022. [DOI: 10.1200/jco.2022.40.4_suppl.347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
347 Background: Brain metastases (BrM) rarely occur in patients with metastatic gastroesophageal adenocarcinoma (GEA) and represent a unique therapeutic challenge. We describe the unique clinical, molecular, and genomic factors associated with mGEA cancer and BrM development in order to help guide future clinical management. Methods: Patients (pts) with GEA seen at Memorial Sloan Kettering Cancer Center (MSKCC) from 2008-2019 and who had consented for genomic tumor profiling with MSK-IMPACT, a capture-based next-generation sequencing platform that detects mutations, copy-number variations, and select fusions, were retrospectively identified. Clinical and pathologic characteristics were reviewed. BrM were identified via International Classification of Diseases (ICD) billing codes and electronic medical record problem lists, and then manually validated. Survival was calculated from the time of BrM diagnosis until date of death or last follow up and estimated using the Kaplan-Meier method. Results: Fifty pts with GEA metastatic to the brain were identified. Most pts were male (86%) and white (80%), with primary tumor of the esophagus/gastroesophageal junction (82%) and intestinal-type Lauren histology (90%). Twenty-three pts (46%) were HER2 positive (defined as IHC 2+/FISH+ or IHC 3+). Frequencies of PTEN (16%) and EGFR (22%) alterations in primary or metastatic sites were enriched in pts with BM compared to that seen across the MSKCC retrospective cohort and the GEA Cancer Genome Atlas (TCGA) cohort. The majority (68%) of pts had stage IV disease at initial diagnosis, and 4 pts were found to have BrM within 1 month (mo) of stage IV diagnosis, while 27 pts developed BrM during therapy. Median time to BrM diagnosis was 18.3 mos (IQR 11.5-28.9) and 15.1 mos from stage IV diagnosis (IQR 4.8-25.5). Median survival was 7.6 mos from BrM diagnosis and 15.6 (95% CI 10.0-NR, n = 19), 7.6 (95% CI 2.5-NR, n = 13), and 4.3 (95% CI 3.5-12.3, n = 18) mos for pts with 1, 2-3, or 4+ BrM, respectively. Conclusions: GEA pts with BrM had increased frequency of HER2 positivity, as well as PTEN and EGFR alterations, compared to GEA pts overall historically. Further correlation between BrM development, molecular characteristics, and survival in a larger cohort will be presented.
Collapse
Affiliation(s)
- Charlton Tsai
- Weill Cornell Medicine/New York Presbyterian, New York, NY
| | | | - Anisha Luthra
- Memorial Sloan Kettering Cancer Center, New York, NY
| | - Joanne F. Chou
- Department of Epidemiology & Biostatistics, Memorial Sloan Kettering, New York, NY
| | - Laura H. Tang
- Memorial Sloan Kettering Cancer Center, New York, NY
| | | | | | | | | | | | | | | | - Kathryn Beal
- Memorial Sloan Kettering Cancer Center, New York, NY
| | - Marinela Capanu
- Department of Epidemiology & Biostatistics, Memorial Sloan Kettering, New York, NY
| | | | | | | |
Collapse
|
4
|
Gillespie EF, Lapen K, Wang DG, Wijetunga N, Pastrana GL, Kollmeier MA, Yamada J, Schmitt AM, Higginson DS, Vaynrub M, Santos Martin E, Xu AJ, Tsai C, Yerramilli D, Cahlon O, Yang T. Replacing 30 Gy in 10 fractions with stereotactic body radiation therapy for bone metastases: A large multi-site single institution experience 2016-2018. Clin Transl Radiat Oncol 2020; 25:75-80. [PMID: 33102818 PMCID: PMC7575833 DOI: 10.1016/j.ctro.2020.10.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2020] [Accepted: 10/02/2020] [Indexed: 12/25/2022] Open
Abstract
Contemporary trends in radiation technique and fractionation for bone metastases at a large academic center with a specialized metastatic program. Stereotactic body radiation therapy (SBRT) is replacing long-course conventional RT for bone metastases. Complexity of RT is increasing, particularly in the community-based regional clinic setting. Single-fraction conventional RT is preferentially employed at the end of life, but prognostic algorithms are needed to further optimize use.
Background Bone metastases cause significant morbidity in patients with cancer, and radiation therapy (RT) is an effective treatment approach. Indications for more complex ablative techniques are emerging. We sought to evaluate RT trends at a large multi-site tertiary cancer center. Methods Patients who received RT for bone metastases at a single institution (including regional outpatient clinics) from 2016 to 2018 were identified. Patients were grouped by RT regimen: single-fraction conventional RT (8 Gy × 1), 30 Gy in 10 fractions, SBRT, and “other”. Multinomial logistic regression was performed to assess trends in regimens over time. Binary logistic regression was performed to evaluate factors associated with receipt of SBRT. Results Between 2016 and 2018, 5,952 RT episodes were received by 2,969 patients with bone metastases. Overall, 76% of episodes were ≤ 5 fractions. The median number of fractions planned for SBRT and non-SBRT episodes was 3 (IQR 3–3) and 5 (IQR 5–10), respectively. Use of SBRT increased from 2016 to 2018 (39% to 53%, p < 0.01) while use of 30 Gy in 10 fractions decreased (26% to 12%, p < 0.01), and 8 Gy × 1 was stable (5.3% to 6.9%, p = 0.28). SBRT was associated with higher performance status (p < 0.01) and non-radiosensitive histology (p < 0.01). Use of SBRT increased in the regional network (19% to 48%, p < 0.01) and at the main center (52% to 59%, p = 0.02), but did not increase within 30 days of death. More patients treated with 8 Gy × 1 than SBRT died within 30 days of treatment (24% vs 3.8%, respectively, p < 0.01). Conclusions SBRT is replacing 30 Gy in 10 fractions for bone metastases, especially among patients with high performance status and non-radiosensitive histologies. Better prognostic algorithms could further improve patient-centered treatment selection at the end of life.
Collapse
Affiliation(s)
- Erin F Gillespie
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.,Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Kaitlyn Lapen
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Diana G Wang
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - N Wijetunga
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Gerri L Pastrana
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Marisa A Kollmeier
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Josh Yamada
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Adam M Schmitt
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Daniel S Higginson
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Max Vaynrub
- Department of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Ernesto Santos Martin
- Department of Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Amy J Xu
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - C Tsai
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Divya Yerramilli
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Oren Cahlon
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - T Yang
- Department of Radiation Oncology, Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| |
Collapse
|
5
|
Mallipattu SK, Jawa R, Moffitt R, Hajagos J, Fries B, Nachman S, Gan TJ, Saltz M, Saltz J, Kaushansky K, Skopicki H, Abell-Hart K, Chaudhri I, Deng J, Garcia V, Gayen S, Kurc T, Bolotova O, Yoo J, Dhaliwal S, Nataraj N, Sun S, Tsai C, Wang Y, Abbasi S, Abdullah R, Ahmad S, Bai K, Bennett-Guerrero E, Chua A, Gomes C, Griffel M, Kalogeropoulos A, Kiamanesh D, Kim N, Koraishy F, Lingham V, Mansour M, Marcos L, Miller J, Poovathor S, Rubano J, Rutigliano D, Sands M, Santora C, Schwartz J, Shroyer K, Spitzer S, Stopeck A, Talamini M, Tharakan M, Vosswinkel J, Wertheim W, Mallipattu SK, Jawa R, Moffitt R, Hajagos J, Fries B, Nachman S, Gan TJ, Saltz M, Saltz J, Kaushansky K, Skopicki H, Abell-Hart K, Chaudhri I, Deng J, Garcia V, Gayen S, Kurc T, Bolotova O, Yoo J, Dhaliwal S, Nataraj N, Sun S, Tsai C, Wang Y, Abbasi S, Abdullah R, Ahmad S, Bai K, Bennett-Guerrero E, Chua A, Gomes C, Griffel M, Kalogeropoulos A, Kiamanesh D, Kim N, Koraishy F, Lingham V, Mansour M, Marcos L, Miller J, Poovathor S, Rubano J, Rutigliano D, Sands M, Santora C, Schwartz J, Shroyer K, Spitzer S, Stopeck A, Talamini M, Tharakan M, Vosswinkel J, Wertheim W. Geospatial Distribution and Predictors of Mortality in Hospitalized Patients With COVID-19: A Cohort Study. Open Forum Infect Dis 2020; 7:ofaa436. [PMID: 33117852 PMCID: PMC7543608 DOI: 10.1093/ofid/ofaa436] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2020] [Accepted: 09/09/2020] [Indexed: 01/20/2023] Open
Abstract
BACKGROUND The global coronavirus disease 2019 (COVID-19) pandemic offers the opportunity to assess how hospitals manage the care of hospitalized patients with varying demographics and clinical presentations. The goal of this study was to demonstrate the impact of densely populated residential areas on hospitalization and to identify predictors of length of stay and mortality in hospitalized patients with COVID-19 in one of the hardest hit counties internationally. METHODS This was a single-center cohort study of 1325 sequentially hospitalized patients with COVID-19 in New York between March 2, 2020, to May 11, 2020. Geospatial distribution of study patients' residences relative to population density in the region were mapped, and data analysis included hospital length of stay, need and duration of invasive mechanical ventilation (IMV), and mortality. Logistic regression models were constructed to predict discharge dispositions in the remaining active study patients. RESULTS The median age of the study cohort (interquartile range [IQR]) was 62 (49-75) years, and more than half were male (57%) with history of hypertension (60%), obesity (41%), and diabetes (42%). Geographic residence of the study patients was disproportionately associated with areas of higher population density (r s = 0.235; P = .004), with noted "hot spots" in the region. Study patients were predominantly hypertensive (MAP > 90 mmHg; 670, 51%) on presentation with lymphopenia (590, 55%), hyponatremia (411, 31%), and kidney dysfunction (estimated glomerular filtration rate < 60 mL/min/1.73 m2; 381, 29%). Of the patients with a disposition (1188/1325), 15% (182/1188) required IMV and 21% (250/1188) developed acute kidney injury. In patients on IMV, the median (IQR) hospital length of stay in survivors (22 [16.5-29.5] days) was significantly longer than that of nonsurvivors (15 [10-23.75] days), but this was not due to prolonged time on the ventilator. The overall mortality in all hospitalized patients was 15%, and in patients receiving IMV it was 48%, which is predicted to minimally rise from 48% to 49% based on logistic regression models constructed to project disposition in the remaining patients on ventilators. Acute kidney injury during hospitalization (odds ratioE, 3.23) was the strongest predictor of mortality in patients requiring IMV. CONCLUSIONS This is the first study to collectively utilize the demographics, clinical characteristics, and hospital course of COVID-19 patients to identify predictors of poor outcomes that can be used for resource allocation in future waves of the pandemic.
Collapse
Affiliation(s)
| | - S K Mallipattu
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - R Jawa
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - R Moffitt
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Hajagos
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - B Fries
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Nachman
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - T J Gan
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - M Saltz
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Saltz
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - K Kaushansky
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - H Skopicki
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - K Abell-Hart
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - I Chaudhri
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Deng
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - V Garcia
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Gayen
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - T Kurc
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - O Bolotova
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Yoo
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Dhaliwal
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - N Nataraj
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Sun
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - C Tsai
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - Y Wang
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Abbasi
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - R Abdullah
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Ahmad
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - K Bai
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - E Bennett-Guerrero
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - A Chua
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - C Gomes
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - M Griffel
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - A Kalogeropoulos
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - D Kiamanesh
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - N Kim
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - F Koraishy
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - V Lingham
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - M Mansour
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - L Marcos
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Miller
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Poovathor
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Rubano
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - D Rutigliano
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - M Sands
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - C Santora
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Schwartz
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - K Shroyer
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Spitzer
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - A Stopeck
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - M Talamini
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - M Tharakan
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Vosswinkel
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - W Wertheim
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S K Mallipattu
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - R Jawa
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - R Moffitt
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Hajagos
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - B Fries
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Nachman
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - T J Gan
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - M Saltz
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Saltz
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - K Kaushansky
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - H Skopicki
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - K Abell-Hart
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - I Chaudhri
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Deng
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - V Garcia
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Gayen
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - T Kurc
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - O Bolotova
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Yoo
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Dhaliwal
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - N Nataraj
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Sun
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - C Tsai
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - Y Wang
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Abbasi
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - R Abdullah
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Ahmad
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - K Bai
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - E Bennett-Guerrero
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - A Chua
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - C Gomes
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - M Griffel
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - A Kalogeropoulos
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - D Kiamanesh
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - N Kim
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - F Koraishy
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - V Lingham
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - M Mansour
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - L Marcos
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Miller
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Poovathor
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Rubano
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - D Rutigliano
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - M Sands
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - C Santora
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Schwartz
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - K Shroyer
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - S Spitzer
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - A Stopeck
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - M Talamini
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - M Tharakan
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - J Vosswinkel
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| | - W Wertheim
- Renaissance School of Medicine at Stony Brook University, Stony Brook University, Stony Brook, New York, USA
| |
Collapse
|
6
|
Yeh E, Wong E, Strohl K, Gu W, Tsai C, Leung L, Yar W, Chiang A. 1202 Validation Of A Novel Wearable Home Sleep Testing Device For Assessment Of Obstructive Sleep Apnea. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.1196] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
There is a substantial need for an accurate and easy-to-use tool for obstructive sleep apnea (OSA) assessment. Belun Ring Platform (BRP), a novel photoplethysmography (PPG)-based home sleep apnea testing system with a proprietary deep learning algorithm, has been shown to have good sensitivity and specificity in predicting OSA in subjects without significant comorbidities and medications known to affect heart rate (HR). In this study, we further tested its performance in subjects referred for in-lab polysomnography (PSG) assessment of sleep disorders without excluding those with non-arrhythmia comorbidities or the subjects on HR-affecting medications.
Methods
PSG was recorded simultaneously with the Ring in the sleep lab and the studies were manually scored by certified sleep technicians according to the AASM Scoring manual version 2.4. Exclusion criteria include age <18, unstable cardiopulmonary status, recent hospitalization within 30 days, significant arrhythmias, baseline HR <50 or >100, home oxygen use, pacemaker/defibrillator, post-cardiac transplantation or Left ventricular assist device.
Results
A cohort of 78 individuals (26 males and 52 females, age 50.5) were studied with 26 taking HR-affecting medications. Of these, 35 (45%) had AHI < 5; 14 (18%) had AHI 5-15; 15 (19%) had AHI 15-30; 14 (18%) had AHI > 30. The Ring-REI correlated well with the PSG-AHI (r =0.83, P <0.001). The accuracy, sensitivity, specificity in categorizing AHI >15 were 0.808, 0.931, and 0.735 respectively. The positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio were 0.675, 0.947, 3.509, and 0.094 respectively. The use of HR-affecting medications did not significantly affect the sensitivity and specificity of BRP in predicting OSA (P =0.16 and 0.44 respectively).
Conclusion
BRP is promising as a reasonable tool for OSA assessment and can potentially be incorporated into a broad spectrum of clinical practices for identification of patients with OSA.
Support
This study is supported by a Grant from Belun Technology Company Limited.
Collapse
Affiliation(s)
- E Yeh
- University Hospitals, CLEVELAND, OH
| | - E Wong
- University Hospitals, CLEVELAND, OH
| | - K Strohl
- University Hospitals, CLEVELAND, OH
| | - W Gu
- Belun Technology Company Limited, Hong Kong, HONG KONG
| | - C Tsai
- Belun Technology Company Limited, Hong Kong, HONG KONG
| | - L Leung
- Belun Technology Company Limited, Hong Kong, HONG KONG
| | - W Yar
- University Hospitals, CLEVELAND, OH
| | - A Chiang
- University Hospitals, CLEVELAND, OH
| |
Collapse
|
7
|
Tsai C, Bellantoni J, Martinez-Uribe O, Peyser B. Training in the Era of EHR: Examining the Experience of Medical Student Documentation in the Ambulatory Care Setting. MedEdPublish (2016) 2020; 9:56. [PMID: 38058909 PMCID: PMC10697456 DOI: 10.15694/mep.2020.000056.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/08/2023] Open
Abstract
This article was migrated. The article was marked as recommended. Purpose: Documenting clinical encounters in the electronic health record has become an important component of medical student training. Reflecting this trend, recent rule changes by the Centers for Medicare and Medicaid services now permit billing for medical student notes. We sought to investigate the educational value of student note-writing following implementation of these changes. Methods: We surveyed medical students at a private research university who participated in longitudinal ambulatory care experiences. Survey questions assessed the incorporation of student note-writing into clinic workflow, as well as the benefits and disadvantages of note-writing. Results: Thirty-six students completed the survey. A majority of students perceived benefits in regards to residency preparedness, engagement with the clinical team, and clinical reasoning ability as a result of writing notes in clinic. While some students reported seeing fewer patients as a result of note-writing, most felt that use of the electronic health record did not negatively impact patient interaction. Barriers cited included a lack of knowledge regarding billing requirements and preceptor apprehension toward student note-writing. Conclusion: The results of this study indicate that student note-writing continues to be a valuable part of medical training following recent billing changes. Our results also identify areas for improvement, including clarifying billing requirements and assuaging preceptor concerns.
Collapse
|
8
|
Wang Y, Yu S, Hsu C, Tsai C, Cheng T. Underestimated fracture risk in postmenopausal women-application of the hybrid intervention threshold. Osteoporos Int 2020; 31:475-483. [PMID: 31696272 DOI: 10.1007/s00198-019-05201-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/25/2019] [Accepted: 10/16/2019] [Indexed: 01/07/2023]
Abstract
UNLABELLED This study evaluated the fragility fracture risk of Taiwanese postmenopausal women with osteopenia. With the incorporation of FRAX and hybrid intervention threshold (HIT), 25% of the participants had high fracture risk. We suggest intervention for fragility fracture for postmenopausal women should be guided by FRAX and HIT instead of bone mineral density alone. INTRODUCTION To explore the risk of fragility fracture in Taiwanese postmenopausal women with osteopenia using the hybrid intervention threshold (HIT) and Fracture Risk Assessment tool (FRAX). METHODS The Taiwan Osteoporosis Association (TOA) conducted a nationwide bone mineral density (BMD) survey between 2008 and 2011 using a bus equipped with a dual-energy X-ray absorptiometry (DXA) machine. All participants completed a structured questionnaire, which included the elements in the FRAX. Based on the results, the group made up of postmenopausal women with osteopenia was identified. In order to explore the risk of fragility fracture by HIT and FRAX among Taiwan postmenopausal women with osteopenia, the 10-year probability of fracture (FRAX score) and individual intervention threshold (IIT) in this group were calculated. If the FRAX score of a participant was higher than or equal to the IIT or fixed intervention threshold (FIT), the participant was considered as above the HIT (HIT could be reached by being over a threshold at either major osteoporotic fracture or hip fracture) and categorized as having a high FRAX fracture risk. RESULTS A total of 13,068 postmenopausal women were enrolled in the program. A total of 5743 (43.9%) participants had osteopenia, of which 1434 (25.0%) had high FRAX fracture risk. CONCLUSIONS One quarter of Taiwanese postmenopausal women with osteopenia had high fragility fracture risk evaluated by FRAX and HIT. Due to the poor sensitivity of BMD for fragility fracture, we suggest that intervention for fragility fracture for postmenopausal women should also be guided by FRAX and HIT instead of BMD alone.
Collapse
Affiliation(s)
- Y Wang
- Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital, No. 123, Dapi Road, Niaosung District, 83301, Kaohsiung City, Taiwan
| | - S Yu
- Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, No. 123, Dapi Road, Niaosung District, 83301, Kaohsiung City, Taiwan
| | - C Hsu
- Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, No. 123, Dapi Road, Niaosung District, 83301, Kaohsiung City, Taiwan
| | - C Tsai
- Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital, No. 123, Dapi Road, Niaosung District, 83301, Kaohsiung City, Taiwan.
| | - T Cheng
- Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, No. 123, Dapi Road, Niaosung District, 83301, Kaohsiung City, Taiwan.
- College of Medicine, Chang Gung University, No. 123, Dapi Road, Niaosung District, 83301, Kaohsiung City, Taiwan.
| |
Collapse
|
9
|
Matsuda F, Lowry L, Suzuki A, Aguilar Fáundez M, Arnold K, Barron D, Bianchini F, Cheung K, Chinone Y, Elleflot T, Fabbian G, Goeckner-Wald N, Hasegawa M, Kaneko D, Katayama N, Keating B, Lee AT, Navaroli M, Nishino H, Paar H, Puglisi G, Richards PL, Seibert J, Siritanasak P, Tajima O, Takatori S, Tsai C, Westbrook B. The POLARBEAR Fourier transform spectrometer calibrator and spectroscopic characterization of the POLARBEAR instrument. Rev Sci Instrum 2019; 90:115115. [PMID: 31779409 DOI: 10.1063/1.5095160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/07/2019] [Accepted: 11/01/2019] [Indexed: 06/10/2023]
Abstract
We describe the Fourier Transform Spectrometer (FTS) used for in-field testing of the POLARBEAR receiver, an experiment located in the Atacama Desert of Chile which measures the cosmic microwave background (CMB) polarization. The POLARBEAR-FTS (PB-FTS) is a Martin-Puplett interferometer designed to couple to the Huan Tran Telescope (HTT) on which the POLARBEAR receiver is installed. The PB-FTS measured the spectral response of the POLARBEAR receiver with signal-to-noise ratio >20 for ∼69% of the focal plane detectors due to three features: a high throughput of 15.1 sr cm2, optimized optical coupling to the POLARBEAR optics using a custom designed output parabolic mirror, and a continuously modulated output polarizer. The PB-FTS parabolic mirror is designed to mimic the shape of the 2.5 m-diameter HTT primary reflector, which allows for optimum optical coupling to the POLARBEAR receiver, reducing aberrations and systematics. One polarizing grid is placed at the output of the PB-FTS and modulated via continuous rotation. This modulation allows for decomposition of the signal into different harmonics that can be used to probe potentially pernicious sources of systematic error in a polarization-sensitive instrument. The high throughput and continuous output polarizer modulation features are unique compared to other FTS calibrators used in the CMB field. In-field characterization of the POLARBEAR receiver was accomplished using the PB-FTS in April 2014. We discuss the design, construction, and operation of the PB-FTS and present the spectral characterization of the POLARBEAR receiver. We introduce future applications for the PB-FTS in the next-generation CMB experiment, the Simons Array.
Collapse
Affiliation(s)
- F Matsuda
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study,The University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - L Lowry
- Department of Physics, University of California, San Diego, California 92093-0424, USA
| | - A Suzuki
- Physics Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Aguilar Fáundez
- Department of Physics and Astronomy, Johns Hopkins University, Baltimore, Maryland 21218, USA
| | - K Arnold
- Department of Physics, University of California, San Diego, California 92093-0424, USA
| | - D Barron
- Department of Physics and Astronomy, University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - F Bianchini
- School of Physics, University of Melbourne, Parkville, VIC 3010, Australia
| | - K Cheung
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - Y Chinone
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study,The University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - T Elleflot
- Department of Physics, University of California, San Diego, California 92093-0424, USA
| | - G Fabbian
- Department of Physics and Astronomy, University of Sussex, Brighton BN1 9QH, United Kingdom
| | - N Goeckner-Wald
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - M Hasegawa
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - D Kaneko
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study,The University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - N Katayama
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo Institutes for Advanced Study,The University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - B Keating
- Department of Physics, University of California, San Diego, California 92093-0424, USA
| | - A T Lee
- Physics Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Navaroli
- Department of Physics, University of California, San Diego, California 92093-0424, USA
| | - H Nishino
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - H Paar
- Department of Physics, University of California, San Diego, California 92093-0424, USA
| | - G Puglisi
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - P L Richards
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - J Seibert
- Department of Physics, University of California, San Diego, California 92093-0424, USA
| | - P Siritanasak
- Department of Physics, University of California, San Diego, California 92093-0424, USA
| | - O Tajima
- Department of Physics, Kyoto University, Kyoto 606-8502, Japan
| | - S Takatori
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan
| | - C Tsai
- Department of Physics, University of California, San Diego, California 92093-0424, USA
| | - B Westbrook
- Radio Astronomy Laboratory, University of California, Berkeley, California 94720, USA
| |
Collapse
|
10
|
Lee J, Cheng N, Tai H, Jimmy Juang J, Wu C, Lin L, Hwang J, Lin J, Chiang F, Tsai C. CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia. J Vasc Surg 2019. [DOI: 10.1016/j.jvs.2019.08.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
11
|
Tung K, Lin C, Chen S, Tan K, Liu Y, Chao Y, Tsai C. EP1.14-06 Clinical Application of an Appropriate Size NGS Panel in Advanced Non-Small Cell Lung Cancer Management: Personal Experience. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
12
|
Chang G, Lam C, Tsai C, Chen Y, Shih J, Aggarwal S, Wang S, Kim S, Kim Y, Wahid I, Li R, Lim W, Sriuranpong V, Chan T, Lorence R, Carriere P, Raabe C, Cseh A, Park K. P1.01-11 Named Patient Use Program for Afatinib in Advanced NSCLC with Progression on Prior Therapy: Experience from Asian Centers. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.567] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
13
|
Chang C, Tsai C, Wu P, Mou C, Chang J. 296 Increased risk of eczema after joint replacement or pacemaker implantation: A population-based cohort study. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
14
|
Ahn M, Han J, Sequist L, Cho B, Lee J, Kim S, Su W, Tsai C, Yang J, Yu H, Horn L, Lee K, Haddad V, Frigault M, Ahmed G, Yang L, Ghiorghiu D, Oxnard G. OA 09.03 TATTON Ph Ib Expansion Cohort: Osimertinib plus Savolitinib for Pts with EGFR-Mutant MET-Amplified NSCLC after Progression on Prior EGFR-TKI. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.377] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
15
|
Lau Y, Klainin-Yobas P, Htun TP, Wong SN, Tan KL, Ho-Lim ST, Chi C, Tsai C, Ong KW, Shorey S, Tam WSW. Electronic-based lifestyle interventions in overweight or obese perinatal women: a systematic review and meta-analysis. Obes Rev 2017; 18:1071-1087. [PMID: 28544551 DOI: 10.1111/obr.12557] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/17/2017] [Revised: 03/21/2017] [Accepted: 03/27/2017] [Indexed: 12/30/2022]
Abstract
Electronic-based (e-based) lifestyle interventions provide potential and cost-effective delivery of remote interventions for overweight and obese perinatal women. To date, no meta-analysis has reported the efficacy of maternal and neonatal outcomes. Seven electronic databases were searched from inception up to July 13, 2016, including the Cumulative Index to Nursing and Allied Health Literature, Cochrane Library, EMBASE, ProQuest Dissertations and Theses, PsycINFO, PubMed and Scopus. Among the 1,145 studies retrieved, 14 randomized controlled trials were selected among 17 publications. The Cochrane risk of bias tool was used to appraise the quality assessment. The meta-analyses demonstrated a significant result for limiting gestational weight gain, losing postnatal weight in 1-2 months, increasing self-reported moderate and vigorous physical activity and reducing caloric intake using diet-related software. Our review shows that an e-based lifestyle intervention is an acceptable approach. The findings reveal the variability in intervention methods and provide limited conclusive evidence. Thus, future studies should examine the efficacy and essential components as well as the various approaches using optimal portions of in-person and phone sessions. Further evaluations comparing the effectiveness of different e-based lifestyle intervention approaches toward activity-related and diet-related outcomes are necessary.
Collapse
Affiliation(s)
- Y Lau
- Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - P Klainin-Yobas
- Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - T P Htun
- Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - S N Wong
- Medical Resource Team, National University of Singapore Libraries, National University of Singapore, Singapore
| | - K L Tan
- Department of Computer Science, National University of Singapore, Singapore
| | - S T Ho-Lim
- Department of Nursing, National University Hospital, Singapore
| | - C Chi
- Department of Obstetrics and Gynecology, National University Hospital, Singapore
| | - C Tsai
- Department of Rehabilitation, National University Hospital, Singapore
| | - K W Ong
- Dietetics, National University Hospital, Singapore
| | - S Shorey
- Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - W S W Tam
- Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| |
Collapse
|
16
|
Lin T, Man M, Elias P, Tsai C, Sheu H, Tsai J, Chih-Hung L. 431 Epidermal pigmentation regulates cutaneous inflammation. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.02.450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
17
|
Yi P, Tsai C, Chang F. 0076 TWO NOVEL ADENOSINE ANALOGUES AS HYPNOTICS. Sleep 2017. [DOI: 10.1093/sleepj/zsx050.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
18
|
Chang C, Chen K, Chen Y, Cheng T, Hsu P, Lai N, Lan J, Lee C, Lee S, Lin H, Tsay G, Yen J, Tsai C, Garg V, Bao Y, Yang M, Wu E. THU0161 Prediction of Flaring in Rheumatoid Arthritis Patients upon Biologics Dose Tapering: A Chart Review Study in Taiwan. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
19
|
Cecchi F, Rabizadeh S, Weingarten P, Tsai C, Zhou L, Hembrough T. P-038 MET activation via exon 14 skipping mutations (METex14del): gastrointestinal prevalence and sensitivity to MET inhibitor AMG337. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw199.36] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
20
|
Chang C, Chen K, Chen Y, Cheng T, Hsu P, Lai N, Lan J, Lee C, Lee S, Lin H, Tsay G, Yen J, Tsai C, Bao Y, Skup M, Yang M, Wu E, Garg V. FRI0196 Real-World Impact of Taiwan Health Policy on Dose Tapering and Withdrawing Biologics in Rheumatoid Arthritis Patients: A Retrospective Chart Review Study. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.4170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
21
|
Abbott D, Adderley P, Adeyemi A, Aguilera P, Ali M, Areti H, Baylac M, Benesch J, Bosson G, Cade B, Camsonne A, Cardman LS, Clark J, Cole P, Covert S, Cuevas C, Dadoun O, Dale D, Dong H, Dumas J, Fanchini E, Forest T, Forman E, Freyberger A, Froidefond E, Golge S, Grames J, Guèye P, Hansknecht J, Harrell P, Hoskins J, Hyde C, Josey B, Kazimi R, Kim Y, Machie D, Mahoney K, Mammei R, Marton M, McCarter J, McCaughan M, McHugh M, McNulty D, Mesick KE, Michaelides T, Michaels R, Moffit B, Moser D, Muñoz Camacho C, Muraz JF, Opper A, Poelker M, Réal JS, Richardson L, Setiniyaz S, Stutzman M, Suleiman R, Tennant C, Tsai C, Turner D, Ungaro M, Variola A, Voutier E, Wang Y, Zhang Y. Production of Highly Polarized Positrons Using Polarized Electrons at MeV Energies. Phys Rev Lett 2016; 116:214801. [PMID: 27284661 DOI: 10.1103/physrevlett.116.214801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/26/2016] [Indexed: 06/06/2023]
Abstract
The Polarized Electrons for Polarized Positrons experiment at the injector of the Continuous Electron Beam Accelerator Facility has demonstrated for the first time the efficient transfer of polarization from electrons to positrons produced by the polarized bremsstrahlung radiation induced by a polarized electron beam in a high-Z target. Positron polarization up to 82% have been measured for an initial electron beam momentum of 8.19 MeV/c, limited only by the electron beam polarization. This technique extends polarized positron capabilities from GeV to MeV electron beams, and opens access to polarized positron beam physics to a wide community.
Collapse
Affiliation(s)
- D Abbott
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Adderley
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Adeyemi
- Hampton University, Hampton, Virginia 23668, USA
| | - P Aguilera
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Ali
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - H Areti
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Baylac
- LPSC, Université Grenoble-Alpes, CNRS/IN2P3, 38026 Grenoble, France
| | - J Benesch
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - G Bosson
- LPSC, Université Grenoble-Alpes, CNRS/IN2P3, 38026 Grenoble, France
| | - B Cade
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Camsonne
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L S Cardman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Clark
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Cole
- Idaho State University, Pocatello, Idaho 83209, USA
| | - S Covert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Cuevas
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - O Dadoun
- LAL, Université Paris-Sud & Université Paris-Saclay, CNRS/IN2P3, 91898 Orsay, France
| | - D Dale
- Idaho State University, Pocatello, Idaho 83209, USA
| | - H Dong
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Dumas
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- LPSC, Université Grenoble-Alpes, CNRS/IN2P3, 38026 Grenoble, France
| | - E Fanchini
- LPSC, Université Grenoble-Alpes, CNRS/IN2P3, 38026 Grenoble, France
| | - T Forest
- Idaho State University, Pocatello, Idaho 83209, USA
| | - E Forman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Freyberger
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Froidefond
- LPSC, Université Grenoble-Alpes, CNRS/IN2P3, 38026 Grenoble, France
| | - S Golge
- North Carolina Central University, Durham, North Carolina 27707, USA
| | - J Grames
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Guèye
- Hampton University, Hampton, Virginia 23668, USA
| | - J Hansknecht
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Harrell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Hoskins
- The College of William & Mary, Williamsburg, Virginia 23187, USA
| | - C Hyde
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - B Josey
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - R Kazimi
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y Kim
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Idaho State University, Pocatello, Idaho 83209, USA
| | - D Machie
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K Mahoney
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Mammei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Marton
- LPSC, Université Grenoble-Alpes, CNRS/IN2P3, 38026 Grenoble, France
| | - J McCarter
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - M McCaughan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M McHugh
- The George Washington University, Washington, DC 20052, USA
| | - D McNulty
- Idaho State University, Pocatello, Idaho 83209, USA
| | - K E Mesick
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA
| | - T Michaelides
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Michaels
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Moffit
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D Moser
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Muñoz Camacho
- IPN, Université Paris-Sud & Université Paris-Saclay, CNRS/IN2P3, 91406 Orsay, France
| | - J-F Muraz
- LPSC, Université Grenoble-Alpes, CNRS/IN2P3, 38026 Grenoble, France
| | - A Opper
- The George Washington University, Washington, DC 20052, USA
| | - M Poelker
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J-S Réal
- LPSC, Université Grenoble-Alpes, CNRS/IN2P3, 38026 Grenoble, France
| | - L Richardson
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Setiniyaz
- Idaho State University, Pocatello, Idaho 83209, USA
| | - M Stutzman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Suleiman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Tennant
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Tsai
- Virginia Polytechnique Institut and State University, Blacksburg, Virginia 24061, USA
| | - D Turner
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Ungaro
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Variola
- LAL, Université Paris-Sud & Université Paris-Saclay, CNRS/IN2P3, 91898 Orsay, France
| | - E Voutier
- LPSC, Université Grenoble-Alpes, CNRS/IN2P3, 38026 Grenoble, France
- IPN, Université Paris-Sud & Université Paris-Saclay, CNRS/IN2P3, 91406 Orsay, France
| | - Y Wang
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y Zhang
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA
| |
Collapse
|
22
|
Lee P, Hsu N, Wu H, Tsai C, Shiao T, Shiao G, Yang C. Prevalence and predictors of nocturnal hypoventilation in amyotrophic-lateral-sclerosis patients with preserved respiratory functions: A two-center trial. Sleep Med 2015. [DOI: 10.1016/j.sleep.2015.02.492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
23
|
Wadhawan R, Gupta M, Laharwal A, Tsai C, Tang S, Hu J, Tan WB, Clara ES, Prakash P, Shabbir A, Lomanto D, Takahashi M, Matsuya H, Nishinari N, Szura M, Pasternak A, Kibil W, Solecki R, Matyja A, Porter A, Berney C, Niebuhr H, Mayer F, Köckerling F, Lal D, Klobusicky P, Feyerherd P, Ates M, Kinaci E, Kose E, Soyer V, Sarici B, Cuglan S, Korkmaz F, Dirican A, Gómez-Menchero J, Jurado PJ, Luque JB, Moreno JG, Grau JMS, Jurado JFG, Giubileo M, Federico L, De Nigris S, Ventura P, García-Pastor P, Carbonell-Tatay F, Torregrosa-Gallud A, Forgione U, Feleshtynsky Y, Vatamanyuk VF, Svyrydovsky SA, Kokhanevych AV, Curado-Soriano A, Infantes-Ormad M, Valera-Sanchez Z, Dominguez-Amodeo A, Naranjo-Fernandez JR, Ruiz Zafra A, Navarrete-Carcer E, Oliva-Mompean F, Padillo-Ruiz J, Brochado J, Farah F, Nicastro RG, Condi GA, De Marco M, Samaan R, Radtke MC, Ji Z, Li J. Topic: Inguinal Hernia - Fixation. Hernia 2015; 19 Suppl 1:S254-60. [PMID: 26518818 DOI: 10.1007/bf03355366] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- R Wadhawan
- Fortis Hospital, Vasant Kunj, New Delhi, India
| | - M Gupta
- Fortis Hospital, Vasant Kunj, New Delhi, India
| | - A Laharwal
- Fortis Hospital, Vasant Kunj, New Delhi, India
| | - C Tsai
- Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan
| | - S Tang
- Minimally Invasive Surgical Centre, Department of Surgery, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore
| | - J Hu
- Minimally Invasive Surgical Centre, Department of Surgery, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore
| | - W B Tan
- Minimally Invasive Surgical Centre, Department of Surgery, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore
| | - E Sta Clara
- Minimally Invasive Surgical Centre, Department of Surgery, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore
| | - P Prakash
- Minimally Invasive Surgical Centre, Department of Surgery, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore
| | - A Shabbir
- Minimally Invasive Surgical Centre, Department of Surgery, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore
| | - D Lomanto
- Minimally Invasive Surgical Centre, Department of Surgery, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore
| | | | - H Matsuya
- Morioka Yuai Hospital, Morioka, Japan
| | | | - M Szura
- I Department of General Surgery, Jagiellonian University, Krakow, Poland
| | - A Pasternak
- I Department of General Surgery, Jagiellonian University, Krakow, Poland.,Department of Anatomy, Jagiellonian University, Krakow, Poland
| | - W Kibil
- I Department of General Surgery, Jagiellonian University, Krakow, Poland
| | - R Solecki
- I Department of General Surgery, Jagiellonian University, Krakow, Poland
| | - A Matyja
- I Department of General Surgery, Jagiellonian University, Krakow, Poland
| | - A Porter
- Bankstown-Lidcombe Hospital, University of New South Wales, Sydney, Australia
| | - C Berney
- Bankstown-Lidcombe Hospital, University of New South Wales, Sydney, Australia
| | - H Niebuhr
- Hanse-Hernienzentrum Hamburg, Hamburg, Germany
| | - F Mayer
- Landeskrankenhaus Salzburg Uniklinikum, Salzburg, Austria
| | | | - D Lal
- National Hospital of Sri Lanka, Colombo, Sri Lanka
| | - P Klobusicky
- Helios St. Elisabeth Hospital, Bad Kissingen, Germany
| | | | - M Ates
- Faculty of Medicine, Department of General Surgery and Liver Transplantation Institute, Inonu University, Malatya, Turkey.,Faculty of Medicine, Department of Anatomy, Inonu University, Malatya, Turkey
| | - E Kinaci
- Faculty of Medicine, Department of General Surgery and Liver Transplantation Institute, Inonu University, Malatya, Turkey.,Department of General Surgery, Istanbul Training and Research Hospital, Istanbul, Turkey
| | - E Kose
- Faculty of Medicine, Department of Anatomy, Inonu University, Malatya, Turkey
| | - V Soyer
- Faculty of Medicine, Department of General Surgery and Liver Transplantation Institute, Inonu University, Malatya, Turkey
| | - B Sarici
- Faculty of Medicine, Department of General Surgery and Liver Transplantation Institute, Inonu University, Malatya, Turkey
| | - S Cuglan
- Faculty of Medicine, Department of Anatomy, Inonu University, Malatya, Turkey
| | - F Korkmaz
- Faculty of Medicine, Department of Anatomy, Inonu University, Malatya, Turkey
| | - A Dirican
- Faculty of Medicine, Department of General Surgery and Liver Transplantation Institute, Inonu University, Malatya, Turkey
| | | | - P J Jurado
- Hospital General Básico de Riotinto, Huelva, Spain
| | | | | | | | | | - M Giubileo
- Ospedale San Carlo Borromeo, Milano, Italy.
| | - L Federico
- Ospedale San Carlo Borromeo, Milano, Italy
| | | | - P Ventura
- Ospedale San Carlo Borromeo, Milano, Italy
| | | | | | | | | | - Y Feleshtynsky
- Optimization of Transabdominal Pre-Peritoneal Alloplasty of Inguinal Hernias, Kyiv, Ukraine
| | | | | | | | | | | | | | | | | | - A Ruiz Zafra
- Hospital Universitario Virgen Macarena, Sevilla, Spain
| | | | | | | | - J Brochado
- Hospital Servidor Publico Estadual, São Paulo, Brazil
| | - F Farah
- Hospital Servidor Publico Estadual, São Paulo, Brazil
| | - R G Nicastro
- Hospital Servidor Publico Estadual, São Paulo, Brazil
| | - G A Condi
- Hospital Servidor Publico Estadual, São Paulo, Brazil
| | - M De Marco
- Hospital Servidor Publico Estadual, São Paulo, Brazil
| | - R Samaan
- Hospital Servidor Publico Estadual, São Paulo, Brazil
| | - M C Radtke
- Hospital Servidor Publico Estadual, São Paulo, Brazil
| | - Z Ji
- Department of General Surgery, Zhongda Hospital, Southeast University, Nanjing, China
| | | |
Collapse
|
24
|
Yasuo S, Kenichi Y, Ueno N, Arimoto A, Hosono M, Yoshikawa T, Toyokawa A, Kakeji Y, Tsai Y, Tsai C, Sul J, Lim M, Park J, Jang CE, Santilli O, Tripoloni D, Santilli H, Nardelli N, Greco A, Estevez M, Sakurai S, Ryu S, Cesana G, Ciccarese F, Uccelli M, Grava G, Castello G, Carrieri D, Legnani G, Olmi S, Naito M, Yamamoto H, Sawada Y, Mandai Y, Asano H, Ino H, Tsukuda K, Nagahama T, Ando M, Ami K, Arai K, Miladinovic M, Kitanovic A, Lechner M, Mayer F, Meissnitzer M, Fortsner R, Öfner D, Köhler G, Jäger T, Kumata Y, Fukushima R, Inaba T, Yaguchi Y, Horikawa M, Ogawa E, Katayama T, Kumar PS, Unal D, Caparlar C, Akkaya T, Mercan U, Kulacoglu H, Barreiro JJ, Baer IG, García LS, Cumplido PL, Florez LJG, Muñiz PF, Fujino K, Mita K, Ohta E, Takahashi K, Hashimoto M, Nagayasu K, Murabayashi R, Asakawa H, Koizumi K, Hayashi G, Ito H, Felberbauer F, Strobl S, Kristo I, Riss S, Prager G, El Komy H, El Gendi A, Nabil W, Karam M, El Kayal S, Chihara N, Suzuki H, Watanabe M, Uchida E, Chen T, Wang J, Wang H, Bouchiba N, Elbakary T, Ramadan A, Elakkad M, Berney C, Vlasov V, Babii I, Pidmurnyak O, Prystupa M, Asakage N, Molinari P, Contino E, Guzzetti L, Oggioni M, Sambuco M, Berselli M, Farassino L, Cocozza E, Crespi A, Ambrosoli A, Zhao Y. Topic: Inguinal Hernia - Unsolved problem in the daily practice. Hernia 2015; 19 Suppl 1:S293-304. [PMID: 26518826 DOI: 10.1007/bf03355374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- S Yasuo
- Department of Surgery. Social Welfare Organization Saiseikai Imperial Gift Foundation, Inc. Saiseikai Wakakusa Hospital, Yokohama, Japan
| | - Y Kenichi
- Department of Surgery. Social Welfare Organization Saiseikai Imperial Gift Foundation, Inc. Saiseikai Wakakusa Hospital, Yokohama, Japan
| | - N Ueno
- Department of General Surgery, Yodogawa Christian Hospital, Osaka, Japan
| | - A Arimoto
- Department of General Surgery, Takatsuki General Hospital, Takatsuki, Japan
| | - M Hosono
- Division of Gastrointestinal Surgery, Kobe University Hospital, Kobe, Japan
| | - T Yoshikawa
- Department of General Surgery, Takatsuki General Hospital, Takatsuki, Japan
| | - A Toyokawa
- Department of General Surgery, Yodogawa Christian Hospital, Osaka, Japan
| | - Y Kakeji
- Division of Gastrointestinal Surgery, Kobe University Hospital, Kobe, Japan
| | - Y Tsai
- Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan
| | - C Tsai
- Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan
| | - J Sul
- Chungnam National University Hospital, Daejeon, South Korea
| | - M Lim
- Chungnam National University Hospital, Daejeon, South Korea
| | - J Park
- Chungnam National University Hospital, Daejeon, South Korea
| | | | - O Santilli
- Centro De Patologia Herniaria, Buenos Aires, Argentina
| | - D Tripoloni
- Centro De Patologia Herniaria, Buenos Aires, Argentina
| | - H Santilli
- Centro De Patologia Herniaria, Buenos Aires, Argentina
| | - N Nardelli
- Centro De Patologia Herniaria, Buenos Aires, Argentina
| | - A Greco
- Centro De Patologia Herniaria, Buenos Aires, Argentina
| | - M Estevez
- Centro De Patologia Herniaria, Buenos Aires, Argentina
| | - S Sakurai
- St. Luke's International Hospital, Tokyo, Japan
| | - S Ryu
- Samsung Changwon Hospital, Changwon-si, Gyeongsangnam-do, South Korea
| | - G Cesana
- School of General Surgery, University of Milan, Milan, Italy.,General and Oncologic Surgery Department, S. Marco Hospital, Zingonia, BG, Italy
| | - F Ciccarese
- School of General Surgery, University of Milan, Milan, Italy.,General and Oncologic Surgery Department, S. Marco Hospital, Zingonia, BG, Italy
| | - M Uccelli
- School of General Surgery, University of Milan, Milan, Italy.,General and Oncologic Surgery Department, S. Marco Hospital, Zingonia, BG, Italy
| | - G Grava
- School of General Surgery, University of Milan, Milan, Italy.,General and Oncologic Surgery Department, S. Marco Hospital, Zingonia, BG, Italy
| | - G Castello
- General and Oncologic Surgery Department, S. Marco Hospital, Zingonia, BG, Italy
| | - D Carrieri
- General and Oncologic Surgery Department, S. Marco Hospital, Zingonia, BG, Italy
| | - G Legnani
- General and Oncologic Surgery Department, S. Marco Hospital, Zingonia, BG, Italy
| | - S Olmi
- School of General Surgery, University of Milan, Milan, Italy.,General and Oncologic Surgery Department, S. Marco Hospital, Zingonia, BG, Italy
| | - M Naito
- Department of Surgery, Okayama Medical Center, Okayama, Japan
| | - H Yamamoto
- Department of Surgery, Okayama Medical Center, Okayama, Japan
| | - Y Sawada
- Himeji Daiichi Hospital, Himeji, Japan
| | - Y Mandai
- Okayama University Hospital, Okayama, Japan
| | - H Asano
- Okayama University Hospital, Okayama, Japan
| | - H Ino
- Okayama University Hospital, Okayama, Japan
| | - K Tsukuda
- Okayama University Hospital, Okayama, Japan
| | - T Nagahama
- Department of Surgery, Toshima Hospital, Tokyo, Japan
| | - M Ando
- Department of Surgery, Toshima Hospital, Tokyo, Japan
| | - K Ami
- Department of Surgery, Toshima Hospital, Tokyo, Japan
| | - K Arai
- Department of Surgery, Toshima Hospital, Tokyo, Japan
| | | | - A Kitanovic
- Surgery ward, General hospital, Krusevac, Serbia
| | - M Lechner
- Department of General Surgery, Paracelsus Medical University, Salzburg, Austria
| | - F Mayer
- Department of General Surgery, Paracelsus Medical University, Salzburg, Austria
| | - M Meissnitzer
- Department of Radiology, Paracelsus Medical University, Salzburg, Austria
| | - R Fortsner
- Department of Radiology, Paracelsus Medical University, Salzburg, Austria
| | - D Öfner
- Department of General Surgery, Paracelsus Medical University, Salzburg, Austria
| | - G Köhler
- Department of General Surgery, Sisters of Charity Hospital, Linz, Austria
| | - T Jäger
- Department of General Surgery, Paracelsus Medical University, Salzburg, Austria
| | - Y Kumata
- Department of Surgery, Teikyo University Hospital, Tokyo, Japan
| | - R Fukushima
- Department of Surgery, Teikyo University Hospital, Tokyo, Japan
| | - T Inaba
- Department of Surgery, Teikyo University Hospital, Tokyo, Japan
| | - Y Yaguchi
- Department of Surgery, Teikyo University Hospital, Tokyo, Japan
| | - M Horikawa
- Department of Surgery, Teikyo University Hospital, Tokyo, Japan
| | - E Ogawa
- Department of Surgery, Teikyo University Hospital, Tokyo, Japan
| | - T Katayama
- Department of Surgery, Teikyo University Hospital, Tokyo, Japan
| | - P S Kumar
- ESI-PGIMSR and Medical College, Bangalore, India
| | - D Unal
- Diskapi Teaching and Research Hospital, Ankara, Turkey
| | - C Caparlar
- Diskapi Teaching and Research Hospital, Ankara, Turkey
| | - T Akkaya
- Diskapi Teaching and Research Hospital, Ankara, Turkey
| | - U Mercan
- Diskapi Teaching and Research Hospital, Ankara, Turkey
| | - H Kulacoglu
- Diskapi Teaching and Research Hospital, Ankara, Turkey
| | | | | | | | | | | | | | - K Fujino
- Department of Surgery, New Tokyo Hospital, Matsudo, Japan
| | - K Mita
- Department of Surgery, New Tokyo Hospital, Matsudo, Japan
| | - E Ohta
- Department of Surgery, New Tokyo Hospital, Matsudo, Japan
| | - K Takahashi
- Department of Surgery, New Tokyo Hospital, Matsudo, Japan
| | - M Hashimoto
- Department of Surgery, New Tokyo Hospital, Matsudo, Japan
| | - K Nagayasu
- Department of Surgery, New Tokyo Hospital, Matsudo, Japan
| | - R Murabayashi
- Department of Surgery, New Tokyo Hospital, Matsudo, Japan
| | - H Asakawa
- Department of Surgery, New Tokyo Hospital, Matsudo, Japan
| | - K Koizumi
- Department of Surgery, New Tokyo Hospital, Matsudo, Japan
| | - G Hayashi
- Department of Surgery, New Tokyo Hospital, Matsudo, Japan
| | - H Ito
- Department of Surgery, New Tokyo Hospital, Matsudo, Japan
| | - F Felberbauer
- Div. of General Surgery, Dpt. of Surgery, Medical University of Vienna, Vienna, Austria
| | | | | | | | | | - H El Komy
- Faculty of medicine, Alexandria, Egypt
| | | | - W Nabil
- Faculty of medicine, Alexandria, Egypt
| | - M Karam
- Faculty of medicine, Alexandria, Egypt
| | | | - N Chihara
- Nippon Medical School, Musashikosugi Hospital, Institute of Gastroenterology, Kawasaki, Japan
| | - H Suzuki
- Nippon Medical School, Musashikosugi Hospital, Institute of Gastroenterology, Kawasaki, Japan
| | - M Watanabe
- Nippon Medical School, Musashikosugi Hospital, Institute of Gastroenterology, Kawasaki, Japan
| | - E Uchida
- Department of Surgery, Nippon Medical School, Tokyo, Japan
| | - T Chen
- Department of Biliary-pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - J Wang
- Department of Biliary-pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - H Wang
- Department of Biliary-pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - N Bouchiba
- Al Wakra Hospital, Hamad Medical Corporation, Al Wakra, Qatar
| | - T Elbakary
- Al Wakra Hospital, Hamad Medical Corporation, Al Wakra, Qatar
| | - A Ramadan
- Al Wakra Hospital, Hamad Medical Corporation, Al Wakra, Qatar
| | - M Elakkad
- Al Wakra Hospital, Hamad Medical Corporation, Al Wakra, Qatar
| | - C Berney
- Bankstown-Lidcombe Hospital, University of NSW, Sydney, Australia
| | - V Vlasov
- Khmelnitskiy regional hospital, Khmelnitskiy, Ukraine
| | | | | | | | - N Asakage
- Department of Surgery, Tsudanuma Central General Hospital, Chiba, Japan
| | - P Molinari
- University Of Insubria Anesthesia and Intensive Care, Varese, Italy
| | - E Contino
- University Of Insubria Anesthesia and Intensive Care, Varese, Italy
| | - L Guzzetti
- Department Of Anesthesia and Palliative Care, University Hospital Of Varese, Varese, Italy
| | - M Oggioni
- Department Of Anesthesia and Palliative Care, University Hospital Of Varese, Varese, Italy
| | - M Sambuco
- Department Of Anesthesia and Palliative Care, University Hospital Of Varese, Varese, Italy
| | - M Berselli
- University Hospital Of Varese Department Of Surgery, Varese, Italy
| | - L Farassino
- University Hospital Of Varese Department Of Surgery, Varese, Italy
| | - E Cocozza
- University Hospital Of Varese Department Of Surgery, Varese, Italy
| | - A Crespi
- University Of Insubria Anesthesia and Intensive Care, Varese, Italy
| | - A Ambrosoli
- Department Of Anesthesia and Palliative Care, University Hospital Of Varese, Varese, Italy
| | - Y Zhao
- Department of vascular Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| |
Collapse
|
25
|
Tsai C, Patel K, Vincent A, Verzosa N, Norris D, Tillis W, Hafner J. 253 Electronic Best Practice Advisories' Effectiveness in Detecting Sepsis in the Emergency Department. Ann Emerg Med 2015. [DOI: 10.1016/j.annemergmed.2015.07.287] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
26
|
Hwang Y, Lin Y, Cheung Y, Tsai C. SU-E-I-45: Feasibility for Using Iodine Quantification to Assist Diagnosis in Dual Energy Contrast-Enhanced Digital Mammography. Med Phys 2015. [DOI: 10.1118/1.4924042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
27
|
Hwang Y, Tsai C, Wei H, Wan Y, Liu H. SU-E-I-47: Quality Survey Using DIGIMAM Phantom for Digital Mammographic Systems. Med Phys 2015. [DOI: 10.1118/1.4924044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
28
|
Lim PX, Patel DR, Poisson KE, Basuita M, Tsai C, Lyndaker AM, Hwang BJ, Lu AL, Weiss RS. Genome Protection by the 9-1-1 Complex Subunit HUS1 Requires Clamp Formation, DNA Contacts, and ATR Signaling-independent Effector Functions. J Biol Chem 2015; 290:14826-40. [PMID: 25911100 DOI: 10.1074/jbc.m114.630640] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2014] [Indexed: 01/30/2023] Open
Abstract
The RAD9A-HUS1-RAD1 (9-1-1) complex is a heterotrimeric clamp that promotes checkpoint signaling and repair at DNA damage sites. In this study, we elucidated HUS1 functional residues that drive clamp assembly, DNA interactions, and downstream effector functions. First, we mapped a HUS1-RAD9A interface residue that was critical for 9-1-1 assembly and DNA loading. Next, we identified multiple positively charged residues in the inner ring of HUS1 that were crucial for genotoxin-induced 9-1-1 chromatin localization and ATR signaling. Finally, we found two hydrophobic pockets on the HUS1 outer surface that were important for cell survival after DNA damage. Interestingly, these pockets were not required for 9-1-1 chromatin localization or ATR-mediated CHK1 activation but were necessary for interactions between HUS1 and its binding partner MYH, suggesting that they serve as interaction domains for the recruitment and coordination of downstream effectors at damage sites. Together, these results indicate that, once properly loaded onto damaged DNA, the 9-1-1 complex executes multiple, separable functions that promote genome maintenance.
Collapse
Affiliation(s)
- Pei Xin Lim
- From the Department of Biomedical Sciences, Cornell University, Ithaca, New York 14853 and
| | - Darshil R Patel
- From the Department of Biomedical Sciences, Cornell University, Ithaca, New York 14853 and
| | - Kelsey E Poisson
- From the Department of Biomedical Sciences, Cornell University, Ithaca, New York 14853 and
| | - Manpreet Basuita
- From the Department of Biomedical Sciences, Cornell University, Ithaca, New York 14853 and
| | - Charlton Tsai
- From the Department of Biomedical Sciences, Cornell University, Ithaca, New York 14853 and
| | - Amy M Lyndaker
- From the Department of Biomedical Sciences, Cornell University, Ithaca, New York 14853 and
| | - Bor-Jang Hwang
- the Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland 21201
| | - A-Lien Lu
- the Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland 21201
| | - Robert S Weiss
- From the Department of Biomedical Sciences, Cornell University, Ithaca, New York 14853 and
| |
Collapse
|
29
|
Tsai C. Essay: freedom. J Bioeth Inq 2015; 12:97-98. [PMID: 25648126 DOI: 10.1007/s11673-015-9615-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/20/2014] [Accepted: 12/11/2014] [Indexed: 06/04/2023]
Abstract
This is a reflective essay written about the humanism evident in a cross-cultural patient-doctor encounter in an HIV clinic in Swaziland, Africa.
Collapse
Affiliation(s)
- C Tsai
- Department of Pediatrics, University of Texas, Southwestern and Children's Medical Center, 1935 Medical District Drive, Dallas, TX, 75235, USA,
| |
Collapse
|
30
|
Abstract
PURPOSE The purpose of this paper is to understand the time spent on various tasks during physician inpatient rounds and to examine the new electronic health records (EHRs) impact on time distribution. DESIGN/METHODOLOGY/APPROACH Trained observers shadowed hospital physicians to record times for various tasks before and after EHR implementation. FINDINGS Electronic records did not improve efficiency. However, task times were redistributed. Physicians spent more time reviewing patient charts using time saved from miscellaneous work. RESEARCH LIMITATIONS/IMPLICATIONS The study focusses solely on work distribution and the changes it underwent. It does not include quality measures either on patient results or physician satisfaction. PRACTICAL IMPLICATIONS As EHR provides rich information and easier access to patient records, it motivates physicians to spend more time reviewing patient charts. Hospital administrators seeking immediate returns on EHR investment, therefore, may be disappointed. ORIGINALITY/VALUE Unlike previous work, this study was conducted in a non-teaching hospital, providing a task-time comparison without any educational and team factor influence. The result serves as a benchmark for many community hospital managers seeking to address the same issue.
Collapse
|
31
|
Park K, Ahn M, Yu C, Kim S, Lin M, Sriuranpong V, Tsai C, Lee J, Kang J, Perez-Moreno P, Button P, Gregory D, Mok T. Aspiration: First-Line Erlotinib (E) Until and Beyond Recist Progression (Pd) in Asian Patients (Pts) with Egfr Mutation-Positive (Mut+) Nsclc. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu349.2] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
32
|
Hsu F, Tsai C, Chang Y, Lee J, Hsieh M, Huang P, Lin C, Hsu C, Cheng J. Clinical Application of the Seventh UICC-AJCC TNM Staging System in Patients Treated With Trimodality Therapy for Esophageal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.1122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
33
|
Tsai C, Beadle B, Li G, Court L, Williamson R, Hofstede T, Eva C, Wei Q, Garden A, Sturgis E. TGF-β1 Single Nucleotide Polymorphism at Rs1982073:t869c Is Predictive of Osteoradionecrosis After Definitive Radiation Therapy for Oropharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.1756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
34
|
Lu S, Tsai C, Wu J, Hsu F, Koong A, Cheng J. Nondosimetric Biomarker of Serum Transforming Growth Factor-β1 Change After Neoadjuvant Chemoradiation Therapy Predicts Postoperative Pulmonary Complications in Esophageal Cancer Patients Receiving Combined Modality Therapy. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
35
|
Lin Y, Hwang Y, Liu H, Wang Y, Tsai C. SU-E-I-40: Survey of Radiation Beam Width in CT According to ACR 2012 CT QC Manual. Med Phys 2013. [DOI: 10.1118/1.4814150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
36
|
Chen J, Kuo S, Tsai C, Cheng J, Wang C. Intensity Modulated Radiation Therapy for T4 Nasopharyngeal Carcinoma: Treatment Outcomes, Patterns of Recurrence, and Feasibility of Salvage Treatment for Locoregional Recurrence. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.1284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
37
|
Tsai C, Cheng J. Investigation on Sonic Hedgehog Signaling Pathway for Radiation Sensitization in Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
38
|
Bau D, Chang W, Lee M, Li F, Tsai C. AOS6 Association of alpha B-crystallin genotypes with oral cancer susceptibility, survival, and recurrence in Taiwan. Eur J Cancer 2012. [DOI: 10.1016/j.ejca.2012.02.023] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
39
|
Tsai C, Chang W, Lee M, Li F, Bau D. AOSOP2 Association of caveolin-1 genotypes with susceptibility to oral cancer in Taiwan. Eur J Cancer 2012. [DOI: 10.1016/j.ejca.2012.02.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
40
|
Tsai C, Zaid T, Co C, Thompson M, Yeung T, Carroll A, Wong K, Mok S. The role of interferon-stimulated gene 15 in advanced stage high-grade serous ovarian adenocarcinoma. Gynecol Oncol 2012. [DOI: 10.1016/j.ygyno.2011.12.342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
41
|
Tsai Y, Tsai C, Wu J, Cheng J. Dominant Advantage in Liver Sparing by Integrating Non-Coplanar Volumetric Modulated Arc Therapy for Left-Lobe Intrahepatic Malignancies. Int J Radiat Oncol Biol Phys 2011. [DOI: 10.1016/j.ijrobp.2011.06.555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
42
|
Tsai C, Chang K, Chiu C, Hsiao S. Combination effects of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) and individual chemotherapeutics in non-small cell lung cancer (NSCLC) cells with and without sensitizing-EGFR mutations. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e18062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
43
|
Shih S, Jung KH, Hsieh TY, Sarathy J, Tsai C, Li KH, Campbel JC, Kwong DL. Photoluminescence and Structure of Chemically Etched Si. ACTA ACUST UNITED AC 2011. [DOI: 10.1557/proc-256-27] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
ABSTRACTWe demonstrate for the first time that chemical etching of Si in HF-HNO3-based solution without applying bias can produce a room temperature photoluminescent porous Si layer. Scanning electron microscope studies reveal a surface morphology similar to that of the conventionally anodized porous Si. The formation mechanism of the chemically etched (CE) film can be explained by a local anodization concept. X-ray diffraction studies on the luminescent CE porous Si show a broad amorphous peak.
Collapse
|
44
|
Chen Y, Kuo T, Fan K, Liang H, Tsai C, Chiang C, Su C. Radon measurements at IC-09 well of Chingshui geothermal field (Taiwan): A case study. RADIAT MEAS 2011. [DOI: 10.1016/j.radmeas.2010.11.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
45
|
Hong J, Chen F, Wang C, Fu S, Tsai C, Chiang C. Partial Recovery from Tumor Bed Effects: Two Distinct Tumor Microenvironments with Different Responses to Therapy. Int J Radiat Oncol Biol Phys 2010. [DOI: 10.1016/j.ijrobp.2010.07.1452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
46
|
Hu C, Wu J, Chao H, Tsai C, Wang C, Cheng J. SU-GG-T-33: An Investigation on the Acquisition and Modification of Cone-Beam Computed Tomography Images for Head and Neck Cancer. Med Phys 2010. [DOI: 10.1118/1.3468419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
47
|
Tsai C, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BW, Eng C, Delclos ME, Krishnan S, Das P. Number of lymph nodes examined and prognosis among pathologically node-negative patients after preoperative chemoradiation for rectal cancer. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.3593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
48
|
Tsai C, Zhou C, Jiang G, Guan Z, Zhao WM, Wu Y. Final safety and efficacy data for Asian patients (pts) in the MO19390 (SAiL) trial: First-line bevacizumab (Bv) plus chemotherapy in advanced or recurrent non-small cell lung cancer (NSCLC). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e18101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
49
|
Yang C, Shih J, Su W, Hsia T, Tsai C, Ou SI, Calvo R, Cong XJ, Shahidi M, Miller VA. A phase II study of BIBW 2992 in patients with adenocarcinoma of the lung and activating EGFR mutations (LUX-Lung 2). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7521] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
50
|
Abstract
SYNOPSIS In this study, we investigated the properties of three different liquid crystal-type humectants prepared through a simple emulsion process. Under a polarized microscope, we observed liquid crystal textures for each of the three moisturizers. When we applied them onto the hands and face, we found that they all provided effective hydration, with pheohydrane/liquid crystal moisturizer exhibiting superior performance. We also investigated the surface properties (contact angle, zeta potential, surface tension, transmission electron microscopy and scanning electron microscopy analyses) after adding pheohydrane to Formula product.
Collapse
Affiliation(s)
- C Tsai
- Department of Applied Cosmetic Science, Ching Kuo Institute of Management & Health, Keelung, Taiwan
| | | | | |
Collapse
|